Trial Outcomes & Findings for ModPG3 Neo-Infant ISO 81060-2:2018 (NCT NCT05976425)

NCT ID: NCT05976425

Last Updated: 2026-02-23

Results Overview

Data shall be analyzed according to the formulas called out in section 6.2.6 of ISO 81060-2:2018/Amd 1:2020.

Recruitment status

TERMINATED

Target enrollment

7 participants

Primary outcome timeframe

Day 1 (up to one hour)

Results posted on

2026-02-23

Participant Flow

One subject at the US site signed informed consent but failed screening prior to enrollment. Per protocol, enrollment occurs at assignment/start; therefore, Actual Enrollment and Started both equal 7 subjects.

Participant milestones

Participant milestones
Measure
All Enrolled Subjects
All subjects who signed informed consent
Overall Study
STARTED
7
Overall Study
COMPLETED
2
Overall Study
NOT COMPLETED
5

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Blood Pressure Readings
n=7 Participants
All enrolled subjects eligible for study participation.
Age, Customized
< 29 days
0 Participants
n=7 Participants
Age, Customized
>= 29 days to < 3 years
7 Participants
n=7 Participants
Sex: Female, Male
Female
1 Participants
n=7 Participants
Sex: Female, Male
Male
6 Participants
n=7 Participants
Region of Enrollment
Italy
7 participants
n=7 Participants
Arm Circumference of ≥3.3-15 cm
7 Participants
n=7 Participants

PRIMARY outcome

Timeframe: Day 1 (up to one hour)

Population: The study was terminated due to errors in the algorithm planned for data processing and analysis. A validated post-processing algorithm for the raw data files was never finalized; therefore, no analyzable blood pressure measurements exist and no participants were analyzed. No future analysis is planned, and no outcome data will ever be available for this study.

Data shall be analyzed according to the formulas called out in section 6.2.6 of ISO 81060-2:2018/Amd 1:2020.

Outcome measures

Outcome data not reported

Adverse Events

Blood Pressure Readings

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Baxter Clinical Trials Disclosure Call Center

Baxter Healthcare

Phone: (224) 948-7359

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place